On CNBC's "Mad Money Lightning Round," Jim Cramer said he really likes Qualtrics International Inc (NASDAQ:XM) as a "long-term growth play."
Analysts strongly agree, giving XM an Outperform consensus rating, according to Benzinga's analyst ratings data.
When asked about Clearfield Inc (NASDAQ:CLFD), he said, "There's an analyst that cut numbers and the stock fell apart. That was ridiculous."
Don't forget to check out our premarket coverage here
Cramer said CRISPR Therapeutics AG (NASDAQ:CRSP) is "one of those crazy science stocks that in this market will work perfectly."
Price Action: Shares of Qualtrics were up 5.74% at $16.66, Clearfield was down 1.2% to $70.60, while CRISPR Therapeutics shares were 2% higher at $52.00 on Wednesday morning.
Now Read This: Over $5M Bet On Uber Technologies? Check Out These 4 Stocks Insiders Are Buying
Photo: Shutterstock